- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04311736
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults (Exergames)
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults (The Exergame Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A treatment that delays the onset of Alzheimer's disease (AD) by five years could be hugely cost-saving at an estimated $89 billion in 2030. However, nearly all (99.6%) drug trials for AD have failed, and no drugs can yet prevent, cure, or even slow AD. This highlights an urgent and pressing need to develop behavioral interventions to prevent AD and slow its progression. Aerobic exercise and cognitive training are two such promising interventions.
Aerobic exercise and cognitive training are 2 promising interventions for preventing AD. Aerobic exercise increases aerobic fitness, which in turn improves brain structure and function, while cognitive training improves selective neural function intensively. Hence, concurrent aerobic exercise and cognitive training may very well have an additive or synergistic effect on cognition by complementary strengthening of different neural functions because aerobic exercise and virtual reality cognitive training depend on discrete neuronal mechanisms for their therapeutic effects.
The purpose of this Phase II randomized controlled trial (RCT) is to test the efficacy and additive/synergistic effects of a 3-month combined cycling and virtual reality cognitive training intervention on cognition and relevant mechanisms (aerobic fitness, physical function), in persons with subjective cognitive decline at risk for developing AD.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Recruiting
- University of Minnesota
-
Contact:
- Russell L Spafford, MS
- Phone Number: 612-626-6045
- Email: spaff010@umn.edu
-
Contact:
- Dereck L Salisbury, PhD
- Phone Number: 612-625-9308
- Email: salis048@umn.edu
-
Principal Investigator:
- Dereck L Salisbury, PhD
-
Principal Investigator:
- Tom Plocher, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cognitive complaint (defines as answering yes to the question "Do you feel that your memory or thinking skills have gotten worse recently within the last 2 years?");
- Not engaging in aerobic exercise or cognitive training >2 days/week, 30 minutes a session in the past 3 months;
- Age 65 years and older;
- Written consent.
- Medical clearance to participate in a supervised exercise program
Exclusion Criteria:
- Resting heart rate > 100 or <50 beats/min with symptoms;
- Dementia or mild cognitive impairment (self-report, diagnosis, or scoring <26 on the Telephone Interview for Cognitive Status;
- Evidence that cognitive decline or memory complaints were caused by underlying neurological or psychiatric disorder or chemical dependency as determined by primary health care provider;
- Current enrollment in another intervention study;
- ACSM contraindications to exercise or other factors that make exercise impossible or unsafe.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Exergame
Moderate intensity cycling only 3 times per week for 12 weeks + concurrent virtual reality cognitive training, supervised by an exercise specialist
|
Cycling on a recumbent cycle ergometer + Virtual Reality Cognitive Training
|
|
Active Comparator: Cycling
Moderate intensity cycling only 3 times per week for 12 weeks, supervised by an exercise specialist
|
Cycling on a recumbent cycle ergometer
|
|
Sham Comparator: Stretching
Stretching 3 times per week for 12 weeks, supervised by a therapist
|
Stretching exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Episodic Memory
Time Frame: change from baseline to 3 months
|
change in composite scores of episodic memory.
Score are automatically computed by NIH Toolbox App,Scoring Process: Item Response Theory (IRT) is used to score the TPVT.
A score known as a theta score is calculated for each participant; it represents the relative overall ability or performance of the participant.
A theta score is very similar to a z-score, which is a statistic with a mean of zero and a standard deviation of one.
|
change from baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive Function
Time Frame: change from baseline to 3 months
|
change in composite measures of executive function, Score are automatically computed by NIH Toolbox App,Scoring Process: Item Response Theory (IRT) is used to score the TPVT.
A score known as a theta score is calculated for each participant; it represents the relative overall ability or performance of the participant.
A theta score is very similar to a z-score, which is a statistic with a mean of zero and a standard deviation of one.
|
change from baseline to 3 months
|
|
Global Cognition
Time Frame: change from baseline to 3 months
|
change in composite measures of global cognition.
Score are automatically computed by NIH Toolbox App,Scoring Process: Item Response Theory (IRT) is used to score the TPVT.
A score known as a theta score is calculated for each participant; it represents the relative overall ability or performance of the participant.
A theta score is very similar to a z-score, which is a statistic with a mean of zero and a standard deviation of one.
|
change from baseline to 3 months
|
|
Aerobic Fitness
Time Frame: change from baseline to 3 months
|
change in 10 meter shuttle walk test
|
change from baseline to 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Function
Time Frame: change from baseline to 3 months
|
change in 6 minute walk test
|
change from baseline to 3 months
|
|
Physical Function
Time Frame: change from baseline to 3 month
|
change in Short Physical Performance Battery Score-Balance
|
change from baseline to 3 month
|
|
Physical Function
Time Frame: change from baseline to 3 months
|
change in short physical performance battery score-Sit to stand
|
change from baseline to 3 months
|
|
Physical Function
Time Frame: change from baseline to 3 months
|
change in short physical performance battery score-4 meter Gait speed
|
change from baseline to 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dereck L Salisbury, PhD, salis048@umn.edu
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EXERGAMES2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
High Point UniversityWake Forest University Health Sciences; Hebrew SeniorLifeRecruitingMild Cognitive Impairment (MCI)United States
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Dr. Schär AG / SPARecruitingMild Cognitive Impairment (MCI)Italy
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Çankırı Karatekin UniversityCompletedMild Cognitive Impairment (MCI)Turkey (Türkiye)
-
University of AlbertaCompleted
-
Friedhelm HummelThe Novartis Foundation; Wyss Center for Bio and Neuroengineering; Clinique Romande... and other collaboratorsCompletedMild Cognitive Impairment (MCI)Switzerland
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)TerminatedAmnestic Mild Cognitive ImpairmentUnited States
Clinical Trials on Exergame
-
MaineHealthRobert Wood Johnson FoundationCompleted
-
University of California, Los AngelesNational Institute on Aging (NIA); BioSensicsActive, not recruitingCognitive Impairment | Dementia | Mild Cognitive Impairment | Memory LossUnited States
-
Chang Gung UniversityCompleted
-
University of MinnesotaCompletedPreclinical Alzheimer's DiseaseUnited States
-
University of ZurichCompletedVestibular DiseasesSwitzerland
-
Eling DeBruinCompletedMild Neurocognitive DisorderSwitzerland
-
National Yang Ming UniversityUnknown
-
Université de MontréalCompleted
-
University of JaénNot yet recruitingExercise | Pregnant Women | Game
-
Eling DeBruinRecruitingMultiple SclerosisSwitzerland